Table 3.
The promoting effect of MSCs in cancers.
| Cells | Tumors | Mode of action | Results | Ref |
|---|---|---|---|---|
| ADSCs | Lung cancer | Paracrine | Promotion | (33) |
|
BMSCs |
Multiple myeloma | Paracrine | Promotion | (24) |
| Lung cancer | EVs | Promotion | (15) | |
| Hu-ADSCs | Breast cancer (Rb+) | Paracrine | Promotion | (13) |
| hUCMSCs | Lung adenocarcinoma | EVs | Promotion | (34) |
| UC-MSCs | Breast cancer | Paracrine | Promotion | (14) |
| Breast cancer (Rb+) | EVs | Promotion | (5, 35) | |
| MSCs | Lung cancer | Paracrine | Promotion | (36) |
| Breast cancer (Rb+) | Cell to cell | Promotion | (6) |
ADSCs, adipose-derived mesenchymal stem cells; Hu-ADSCs, human adipose-derived stem cells; hUCMSCs, UC-MSCs, human umbilical cord stroma-derived MSCs.